CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanetsky, P. A.
Right arrow Articles by Rebbeck, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanetsky, P. A.
Right arrow Articles by Rebbeck, T. R.
Cancer Epidemiology Biomarkers & Prevention Vol. 13, 808-819, May 2004
© 2004 American Association for Cancer Research

Assessment of Polymorphic Variants in the Melanocortin-1 Receptor Gene with Cutaneous Pigmentation Using an Evolutionary Approach

Peter A. Kanetsky1,4,5, Fan Ge2, Derek Najarian4, Jennifer Swoyer4, Saarene Panossian4, Lynn Schuchter3,5, Robin Holmes5, DuPont Guerry3,5 and Timothy R. Rebbeck1,4,5

1 Departments of Biostatistics and Epidemiology, 2 Department of Biology, 3 Department of Medicine, Division of Hematology-Oncology, 4 Center for Clinical Epidemiology and Biostatistics, and 5 Melanoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania

Requests for reprints: Peter A. Kanetsky, Center for Clinical Epidemiology and Biostatistics and Epidemiology, University of Pennsylvania, 903 Blockley Hall, Philadelphia, PA 19104-6021. Phone: (215) 573-3282. E-mail: pkanetsk{at}cceb.med.upenn.edu.

The melanocortin-1 receptor gene (MC1R) encodes a membrane-bound receptor protein that is central to melanin synthesis. The coding region of MC1R is highly polymorphic and associations of variants with pigmentation phenotypes and risk for cutaneous neoplasms have been reported. We sought to determine the distribution and frequency of MC1R variants and their relationship to pigmentation characteristics in 179 Caucasian controls from the United States. One hundred thirty-five (75.4%) subjects carried one or more variants, and we determined that carriage of the previously designated "red hair color" (RHC) alleles, R151C, R160W, and D294H was strongly associated with fair pigmentation phenotypes including light hair and eye color, tendency to burn, decreased tendency to tan, and freckling. We used SIFT software to define MC1R protein positions that were predicted intolerant to amino acid substitutions; detected variants that corresponded to intolerant substitutions were D84E, R142H, R151C, I155T, R160W, and D294H. Carriage of one or more of these putative functionally important variants or the frameshift variant ins86A was significantly associated with fair pigmentation phenotypes. Analyses limited to carriage of ins86A and the three non-RHC alleles identified by SIFT were attenuated and no longer reached statistical significance. This is the first study to describe MC1R variants among control subjects from the U.S. Our results indicate that the frequency of variants is similar to that previously observed among non-U.S. Caucasians. Risk variants defined by either the published literature or by evolutionary criteria are strongly and significantly associated with all fair pigmentation phenotypes that were measured.

Key Words: melanocortin-1 receptor • pigmentation • genotype-phenotype • polymorphism




This article has been cited by other articles:


Home page
ScienceHome page
C. Lalueza-Fox, H. Rompler, D. Caramelli, C. Staubert, G. Catalano, D. Hughes, N. Rohland, E. Pilli, L. Longo, S. Condemi, et al.
A Melanocortin 1 Receptor Allele Suggests Varying Pigmentation Among Neanderthals
Science, November 30, 2007; 318(5855): 1453 - 1455.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. A. Beaumont, S. L. Shekar, R. A. Newton, M. R. James, J. L. Stow, D. L. Duffy, and R. A. Sturm
Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles
Hum. Mol. Genet., September 15, 2007; 16(18): 2249 - 2260.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Fernandez, R. Milne, J Bravo, J. Lopez, J. Aviles, M. Longo, J Benitez, P Lazaro, and G Ribas
MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population
Carcinogenesis, August 1, 2007; 28(8): 1659 - 1664.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. A. Kanetsky, T. R. Rebbeck, A. J. Hummer, S. Panossian, B. K. Armstrong, A. Kricker, L. D. Marrett, R. C. Millikan, S. B. Gruber, H. A. Culver, et al.
Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma.
Cancer Res., September 15, 2006; 66(18): 9330 - 9337.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. Chaudru, K. Laud, M.-F. Avril, A. Miniere, A. Chompret, B. Bressac-de Paillerets, F. Demenais, and The French Familial Melanoma Study Group
Melanocortin-1 Receptor (MC1R) Gene Variants and Dysplastic Nevi Modify Penetrance of CDKN2A Mutations in French Melanoma-Prone Pedigrees
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2384 - 2390.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. T. Landi, P. A. Kanetsky, S. Tsang, B. Gold, D. Munroe, T. Rebbeck, J. Swoyer, M. Ter-Minassian, M. Hedayati, L. Grossman, et al.
MC1R, ASIP, and DNA Repair in Sporadic and Familial Melanoma in a Mediterranean Population
J Natl Cancer Inst, July 6, 2005; 97(13): 998 - 1007.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. Tchernitchko, M. Goossens, and H. Wajcman
In Silico Prediction of the Deleterious Effect of a Mutation: Proceed with Caution in Clinical Genetics
Clin. Chem., November 1, 2004; 50(11): 1974 - 1978.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.